Main Topics

• Anti-inflammatory therapies
• Antithrombotic strategies (including DOACs)
• Arrhythmias
• Vaccines
• Biomarkers
• Diabetes
• Epidemiology and risk factors
• Fabry disease
• Interventional approaches in young patients
• Genetic susceptibility (FH, Lp(a), polygenic risk)
• GLP-1
• Hypertension
• Hypertrophic cardiomyopathy
• Hereditary cardiomyopathies (HKMP)
• Inflammation
• Cardiomyopathies
• Coronary imaging
• Lipid-lowering therapies: how aggressive should we be?
• Rare hereditary/metabolic diseases
• Rare cardiomyopathies
• Obesity
• Case discussions
• Autoimmune diseases
• Special populations (pregnancy, athletes, HIV, COVID)
• Thrombophilias
• Thromboses
• Recreational drugs, medications and energy drinks
• Artificial intelligence, omics technologies and registry studies
• Lifestyle and environmental factors